Daniel T. Lackland

Dr. Daniel T. Lackland is Professor of Epidemiology at the Medical University of South Carolina. He is a Fellow in the American College of Epidemiology, American Society of Hypertension, and American Heart Association. He directs the Division of Translational Neuroscience and Population Studies, and the Masters of Science in Clinical Research Program. Dr. Lackland was appointed to the panel for the Eighth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 8), and the work group for the NHLBI Clinical Guidelines for Cardiovascular Risk Reduction (Global Risk Assessment). He currently serves on the Evidence Rating Committee of the ACC/AHA Clinical Practice Guidelines (Hypertension). He chairs the Oversight Committee for AHA Strategically Focused Research Network on Hypertension, and serves on the Data Safety Monitoring Board for several ongoing NIH sponsored clinical trials. Much of his research interest involves the population risk assessment of cardiovascular disease, stroke and hypertension. He is the principal investigator for the NIH-funded Black Pooling Project assessing the disparities in cardiovascular diseases and hypertension, and is subcontract PI for “Impact of Nativity on Cardiometabolic Syndrome Factors” in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. For more than two decades, he worked closely with the late Professor David Barker on the fetal and early life origins of high blood pressure and hypertension-related outcomes. In addition to these epidemiological investigations, Professor Lackland is involved in population high blood pressure control efforts with over 240 scientific journal publications. He is President of the World Hypertension League and serves on the boards of the Carolinas Center for Medical Excellence, Consortium for Southeastern Hypertension Control (COSEHC), and Inter-American Society of Hypertension. He is Deputy Editor-In-Chief of the Journal of Clinical Hypertension, and member of the editorial boards of Hypertension, Ethnicity and Disease, Journal of the American Society of Hypertension, and Advances in Cardiovascular Therapeutic.